It is anticipated to get approvals by end 2010 or early quarter of 2011, this information was received from the company who manufactures Pradaxa - Boehringer Ingelheim
Pradaxa, also known as dabigatran etexilate, as well as Bayer and J&J's Xarelto pill, were designed to replace the Warfarin pill, introduced in 1954.
Warfarin, the standard therapy in stroke prevention, interacts with food and other medicines and doctors must monitor patients' blood frequently. The new generation of anti-clotting pills does not have these drawbacks.
Bristol-Myers Squibb and Pfizer are working on a similar compound called apixaban.
Hope to have answered your question to satisfaction?
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 27 Nov 2010 • 1 answer
Posted 17 Jan 2011 • 1 answer
Posted 2 Jun 2011 • 1 answer
Posted 16 Nov 2011 • 2 answers
Posted 18 Feb 2012 • 1 answer